Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|December 9, 2016
Potential Application of 5-Aryl-Substituted 2-Aminobenzamide Type of HDAC1/2- Selective Inhibitors to PharmaceuticalsShinichi Uesato, Yoshiyuki Hirata, Tsutomu Sasaki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Isoform Selectivity of HDAC Inhibitors Has a Significant Effect on PD-L1 Expression in the Triple-negative Cancer Cell Line MDA-MB-231]Hinata Nishino, Yoshiyuki Hirata, Yasuo Nagaoka, et al.
Biological & Pharmaceutical Bulletin|June 4, 2008
Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cellsYasuo Nagaoka, Kota Otsuki, Tetsuro Fujita, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virusKyoko Hayashi, Kazuto Narutaki, Yasuo Nagaoka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2008
Attempt to detect natural anticancer compounds--protein binding through precursor ion scan and MS/MS measurementsJun Negishi, Tatsuya Shirahama, Yasuo Nagaoka, et al.
Chemical & Pharmaceutical Bulletin|September 19, 2002
N-substituted hydroxyureas as urease inhibitorsShinichi Uesato, Yuichiro Hashimoto, Masaru Nishino, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Antiviral activity of berberine and related compounds against human cytomegalovirusKyoko Hayashi, Kazuki Minoda, Yasuo Nagaoka, et al.
Environmental Toxicology and Pharmacology|December 29, 2014
Influence of the carbamate fungicide benomyl on the gene expression and activity of aromatase in the human breast carcinoma cell line MCF-7Yasuyuki Kawaratani, Takeshi Matsuoka, Yoshiyuki Hirata, et al.
European Journal of Medicinal Chemistry|July 28, 2009
Histone deacetylase inhibitor prodrugs in nanoparticle vector enhanced gene expression in human cancer cellsYuta Ishii, Yoshiyuki Hattori, Toshiharu Yamada, et al.
Neuroscience Letters|November 26, 2022
Isozyme-specific histone deacetylase 1/2 inhibitor K560 attenuates oxidative stress-induced retinal cell deathHiroshi Tawarayama, Yoshiyuki Hirata, Keiko Uchida, et al.
Pageof 4